The U.S. Food and Drug Administration (FDA) on Friday cleared Dexcom Inc.‘s DXCM Stelo Glucose Biosensor System for ...
Authorization of Stelo integrated CGM extends to children without diabetes as well ...
CGMs can help people avoid serious diabetes complications, save money through better management and adjust behavior based on feedback.
Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...